NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia | MicrobiomeTrials← Back to trialsNCT06238050
NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-04-15Est. Completion: 2026-12
Enrollment target: 200 participants Locations- University Hospital, Angers, France
- Hospital Center, Cholet, France
- Hospital Center, Le Mans, France
Other microbiome trials you might be interested in
Critical Limb Ischemia
Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrap…
St. Helena, United StatesEst. completion Apr 30, 2026
CLTI Defined as Rutherford Category 4 or 5PAOD (Peripheral Arterial Obstructive Disease)
The aim of this clinical trial is to learn if the resorbable scaffold can be successfully implanted in below-the-knee ar…
Tashkent, UzbekistanEst. completion Dec 1, 2026